US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 30.410
  • -1.150-3.64%
Trading Jul 3 12:23 ET
3.17BMarket Cap28.96P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corcept Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

146.81M

+38.95%
EPS(YoY)

0.25

+78.57%
Analyst Rating

Strong Buy

Jul 3, 2024

Corcept Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 162.077M--
--2024/Q2-- / 155.217M--
May 1, 20242024/Q1146.808M / 141.202M--
Feb 15, 20242023/Q4135.405M / 129.298M--
Nov 1, 20232023/Q3123.601M / 119.723M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 162.077M--
--2024/Q2-- / 155.217M--
May 1, 20242024/Q1146.808M / 141.202M--
Feb 15, 20242023/Q4135.405M / 129.298M--
Nov 1, 20232023/Q3123.601M / 119.723M--

Unlock Free Earnings Estimates

Corcept Therapeutics Earnings Reports

  • Corcept Therapeutics | 10-Q: Quarterly report

    May 1 16:18 ET

  • Corcept Therapeutics | 10-K: Annual report

    Feb 15 16:23 ET

  • Corcept Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 1, 2023 16:16 ET

  • Corcept Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 3, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg